Skip to main content

IMI statement on the European Parliament vote on IMI's budget implementation and accounts for 2014


Brussels, Belgium, 28 April 2016 - The Innovative Medicines Initiative (IMI) is extremely pleased that the European Parliament has voted today to grant it discharge on its budget implementation and closure of accounts for the financial year 2014.

The report approved by the parliament recognises the efforts IMI has made over the years to ensure that it applies high standards of management and control to its use of funds. Furthermore, IMI has already started implementing the new recommendations made by Members of the European Parliament (MEPs) in their report.